Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT
Phase 3
Completed
- Conditions
- Hematological MalignanciesHematopoietic Stem Cell Transplantation
- Interventions
- Other: PBSCsOther: BMSCsOther: Cord
- First Posted Date
- 2022-03-22
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 314
- Registration Number
- NCT05290545
- Locations
- 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Site Preservation After Tooth Extraction
Not yet recruiting
- Conditions
- Osteogenesis ImperfectaTotal Absence of Permanent TeethTooth Socket
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 88
- Registration Number
- NCT05258019
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
Phase 4
- Conditions
- PneumoniaThrombocytopenia
- Interventions
- Drug: normal saline
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 178
- Registration Number
- NCT05217719
An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"
Recruiting
- Conditions
- Liver Abscess, PyogenicInfectionsAbscessLiver Abscess
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 160
- Registration Number
- NCT05213949
- Locations
- 🇨🇳
NanFang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
Phase 2
Recruiting
- Conditions
- Advanced Esophageal Squamous Cell Carcinoma
- Interventions
- Drug: Anlotinib/Penpulimab/ChemotherapyDrug: Penpulimab/Chemotherapy
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT05214222
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)
Phase 4
- Conditions
- Hepatitis B, ChronicMother to Child Transmission
- Interventions
- Drug: antiviral prophylaxis with Tenofovir Alafenamide Fumarate
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 330
- Registration Number
- NCT05177926
- Locations
- 🇨🇳
Guangdong Maternal and Child Care Hospital, Guangzhou, China
🇨🇳The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, China
🇨🇳The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
Mother-to-child Transmission of HBV in China
Recruiting
- Conditions
- Hepatitis B, ChronicMother to Child Transmission
- Interventions
- Other: comprehensive management algorithm for preventing mother-to-child transmission of HBV
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2021-12-29
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 50000
- Registration Number
- NCT05172453
- Locations
- 🇨🇳
302 military hospital of China, Beijing, China
🇨🇳Zhujiang Hospital, Southern Medical University, Guangzhou, China
🇨🇳Xixi Hospital of Hangzhou, Hangzhou, China
Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2021-12-28
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 35
- Registration Number
- NCT05171309
- Locations
- 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Recruiting
- Conditions
- DPMAS Therapy in Liver Disease Patients
- Interventions
- Other: Double plasma molecular absorption system
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 1300
- Registration Number
- NCT05129904
- Locations
- 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China
Omics Sequencing of Exosomes in Body Fluids of Patients With Acute Lung Injury
Recruiting
- Conditions
- Acute Lung Injury
- Interventions
- Diagnostic Test: The lungs causes and extrapulmonary factors
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 180
- Registration Number
- NCT05058768
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath